Triple-negative breast cancers (TNBCs), i.e. tumors lacking ER-, PR- or HER2-expression, are also enriched for EMT/CSC features when compared to ER-, PR- or HER2-positive breast cancers, consistent with the fact that the majority of basal tumors are also TNBCs [39]. Here, ERBB2 is linked to breast carcinoma.